🇺🇸 FDA
Patent

US 11643388

Inhibitors of alpha 2 beta 1 integrin and methods of use thereof

granted A61PA61P11/06

Quick answer

US patent 11643388 (Inhibitors of alpha 2 beta 1 integrin and methods of use thereof) held by The Regents of the University of California expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P11/06